Katleen Verleysen

Dr. Katleen Verleysen joined miDiagnostics as CEO in May 2021. She has been active in the Life Sciences sector for over 20 years and has held various CEO, Senior Management positions and Board roles across the sector.

This includes CEO roles at Pronota (Belgium) and DNameIT (Belgium). She has also held positions at Serenex (USA), ImmunExpress (USA), Oxford Biodynamics (UK), PharmaFluidics (Belgium), and the Center for Medical Innovation (Belgium). She has successfully completed multiple rounds of funding for many of these companies during her tenure.

Prior to joining miDiagnostics, she was responsible for finetuning imec’s healthcare strategy, as well as enabling strategic partnerships. She is currently a Board member of Immunexpress, a Seattle based diagnostics company, representing the Janssen Family Office. Katleen holds a B.Sc. in Chemistry and a Ph.D. in Analytical Chemistry, from the University of Ghent, Belgium. Katleen also received a postdoctoral fellowship from the Medical Center of Duke University (NC, USA).